IRIS Accounts Production v25.2.0.378 10027766 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100277662024-03-31100277662025-03-31100277662024-04-012025-03-31100277662023-01-31100277662023-02-012024-03-31100277662024-03-3110027766ns15:EnglandWales2024-04-012025-03-3110027766ns14:PoundSterling2024-04-012025-03-3110027766ns10:Director12024-04-012025-03-3110027766ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3110027766ns10:SmallEntities2024-04-012025-03-3110027766ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3110027766ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3110027766ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3110027766ns10:FullAccounts2024-04-012025-03-311002776612024-04-012025-03-3110027766ns10:EntityNoLongerTradingButTradedInPast2024-04-012025-03-3110027766ns10:OrdinaryShareClass12024-04-012025-03-3110027766ns10:OrdinaryShareClass22024-04-012025-03-3110027766ns10:OrdinaryShareClass32024-04-012025-03-3110027766ns5:CurrentFinancialInstruments2025-03-3110027766ns5:CurrentFinancialInstruments2024-03-3110027766ns5:Non-currentFinancialInstruments2025-03-3110027766ns5:Non-currentFinancialInstruments2024-03-3110027766ns5:ShareCapital2025-03-3110027766ns5:ShareCapital2024-03-3110027766ns5:SharePremium2025-03-3110027766ns5:SharePremium2024-03-3110027766ns5:RetainedEarningsAccumulatedLosses2025-03-3110027766ns5:RetainedEarningsAccumulatedLosses2024-03-3110027766ns10:RegisteredOffice2024-04-012025-03-3110027766ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110027766ns5:LeaseholdImprovements2024-04-012025-03-3110027766ns5:PlantMachinery2024-04-012025-03-3110027766ns5:FurnitureFittings2024-04-012025-03-3110027766ns5:ComputerEquipment2024-04-012025-03-3110027766ns5:IntangibleAssetsOtherThanGoodwill2024-03-3110027766ns5:IntangibleAssetsOtherThanGoodwill2025-03-3110027766ns5:IntangibleAssetsOtherThanGoodwill2024-03-3110027766ns5:LeaseholdImprovements2024-03-3110027766ns5:PlantMachinery2024-03-3110027766ns5:FurnitureFittings2024-03-3110027766ns5:ComputerEquipment2024-03-3110027766ns5:LeaseholdImprovements2025-03-3110027766ns5:PlantMachinery2025-03-3110027766ns5:FurnitureFittings2025-03-3110027766ns5:ComputerEquipment2025-03-3110027766ns5:LeaseholdImprovements2024-03-3110027766ns5:PlantMachinery2024-03-3110027766ns5:FurnitureFittings2024-03-3110027766ns5:ComputerEquipment2024-03-3110027766ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3110027766ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3110027766ns10:OrdinaryShareClass12025-03-3110027766ns10:OrdinaryShareClass22025-03-3110027766ns10:OrdinaryShareClass32025-03-31
REGISTERED NUMBER: 10027766 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Stride Healthcare Limited

Stride Healthcare Limited (Registered number: 10027766)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Balance Sheet 1

Notes to the Financial Statements 3


Stride Healthcare Limited (Registered number: 10027766)

Balance Sheet
31 March 2025

2025 2024
Notes £    £    £    £   
Fixed assets
Intangible assets 4 2,031 3,006
Tangible fixed assets 5 26,117 34,329
28,148 37,335

Current assets
Stock 1,000 1,200
Debtors 6 84,832 36,233
Cash at bank and in hand 26,469 33,706
112,301 71,139
Creditors: amounts falling due within
one year

7

74,741

53,938
Net current assets 37,560 17,201
Total assets less current liabilities 65,708 54,536

Creditors: amounts falling due after
more than one year

8

(49,000

)

(49,000

)

Provisions for liabilities (3,181 ) -
Net assets 13,527 5,536

Stride Healthcare Limited (Registered number: 10027766)

Balance Sheet - continued
31 March 2025

2025 2024
Notes £    £    £    £   
Capital and reserves
Called up share capital 9 100 100
Share premium 9,980 9,980
Retained earnings 3,447 (4,544 )
Shareholders' funds 13,527 5,536

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 August 2025 and were signed on its behalf by:





C C Davis - Director


Stride Healthcare Limited (Registered number: 10027766)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. Statutory information

Stride Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10027766

Registered office: 85 Church Road
Hove
East Sussex
BN3 2BB

The presentation currency of the financial statements is in Pound Sterling (£) and rounding is to the nearest (£).

The prior period covered by the financial statements was 14 months from 1 February 2023 to 31 March 2024 to align with the fiscal year, therefore comparatives are not entirely comparable.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts.

When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period.

When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at
cost less any accumulated amortisation and any accumulated impairment losses.

The intangible asset is being amortised evenly over its estimated useful life of 4 years.

Stride Healthcare Limited (Registered number: 10027766)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. Accounting policies - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 10% on cost
Plant and machinery - 25% on cost
Fixtures and fittings - 25% on cost
Computer equipment - 33% on cost

Tangible fixed assets are initially recorded at cost and subsequently recorded at cost less accumulated depreciation. Cost includes costs directly attributable to making the asset capable of operating as intended.

Stocks
Stock are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Stock are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing stock to its present location and condition. Stock is calculated using the first-in, first-out formula. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Stride Healthcare Limited (Registered number: 10027766)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. Accounting policies - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. Employees and directors

The average number of employees during the year was 8 (2024 - 6 ) .

4. Intangible fixed assets
Other
intangible
assets
£   
Cost
At 1 April 2024
and 31 March 2025 3,900
Amortisation
At 1 April 2024 894
Charge for year 975
At 31 March 2025 1,869
Net book value
At 31 March 2025 2,031
At 31 March 2024 3,006

Stride Healthcare Limited (Registered number: 10027766)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

5. Tangible fixed assets
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
Cost
At 1 April 2024 29,849 8,000 2,949 3,978 44,776
Additions - 6,660 - - 6,660
At 31 March 2025 29,849 14,660 2,949 3,978 51,436
Depreciation
At 1 April 2024 6,604 1,833 674 1,336 10,447
Charge for year 9,850 2,972 737 1,313 14,872
At 31 March 2025 16,454 4,805 1,411 2,649 25,319
Net book value
At 31 March 2025 13,395 9,855 1,538 1,329 26,117
At 31 March 2024 23,245 6,167 2,275 2,642 34,329

6. Debtors: amounts falling due within one year
2025 2024
£    £   
Trade debtors 47,732 29,233
Other debtors 37,100 7,000
84,832 36,233

7. Creditors: amounts falling due within one year
2025 2024
£    £   
Trade creditors 20,588 9,212
Taxation and social security 18,642 6,018
Other creditors 35,511 38,708
74,741 53,938

8. Creditors: amounts falling due after more than one year
2025 2024
£    £   
Other creditors 49,000 49,000

Stride Healthcare Limited (Registered number: 10027766)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

9. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
51 Ordinary A £1 51 51
29 Ordinary B £1 29 29
20 Ordinary C £1 20 20
100 100